These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16011670)

  • 1. Histamine receptor antagonists and incident colorectal adenomas.
    Robertson DJ; Burke CA; Schwender BJ; Wargovich MJ; Greenberg ER; Sandler RS; Ahnen DJ; Rothstein R; Mott LA; Baron JA
    Aliment Pharmacol Ther; 2005 Jul; 22(2):123-8. PubMed ID: 16011670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrin, Helicobacter pylori, and colorectal adenomas.
    Robertson DJ; Sandler RS; Ahnen DJ; Greenberg ER; Mott LA; Cole BF; Baron JA
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):163-7. PubMed ID: 18929688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat, fiber, meat and the risk of colorectal adenomas.
    Robertson DJ; Sandler RS; Haile R; Tosteson TD; Greenberg ER; Grau M; Baron JA
    Am J Gastroenterol; 2005 Dec; 100(12):2789-95. PubMed ID: 16393237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
    Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
    Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
    Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful therapy of a severe dextran incident using histamin H1- and H2-receptor blockaders].
    Lindenmaier HL; Preiss D; Kuner EH
    Chirurg; 1978 Aug; 49(8):514-6. PubMed ID: 28913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystectomy and the risk of recurrent colorectal adenomas.
    Vinikoor LC; Robertson DJ; Baron JA; Silverman WB; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1523-5. PubMed ID: 17627020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
    Grau MV; Baron JA; Sandler RS; Wallace K; Haile RW; Church TR; Beck GJ; Summers RW; Barry EL; Cole BF; Snover DC; Rothstein R; Mandel JS
    J Natl Cancer Inst; 2007 Jan; 99(2):129-36. PubMed ID: 17227996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium and colorectal adenoma: results of a pooled analysis.
    Jacobs ET; Jiang R; Alberts DS; Greenberg ER; Gunter EW; Karagas MR; Lanza E; Ratnasinghe L; Reid ME; Schatzkin A; Smith-Warner SA; Wallace K; Martínez ME
    J Natl Cancer Inst; 2004 Nov; 96(22):1669-75. PubMed ID: 15547179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
    Chung SJ; Kim YS; Yang SY; Song JH; Kim D; Park MJ; Kim SG; Song IS; Kim JS
    Gut; 2011 Nov; 60(11):1537-43. PubMed ID: 21427200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pancreatitis and the role of histamine-2 receptor antagonists: a meta-analysis of randomized controlled trials of cimetidine.
    Morimoto T; Noguchi Y; Sakai T; Shimbo T; Fukui T
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):679-86. PubMed ID: 12072603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of histamine H1+H2 receptor antagonists on abdominal infections following minimally invasive versus conventional surgery: studies in large samples of rats following the new concept of clinic modelling randomised trials (CMRT).
    Celik I; Nies C; Lorenz W; Sitter H; Stinner B; Krack W; Krackrügge D; Krömer JH; Rothmund M
    Inflamm Res; 1999 Apr; 48 Suppl 1():S51-2. PubMed ID: 10350159
    [No Abstract]   [Full Text] [Related]  

  • 15. Five-year colon surveillance after screening colonoscopy.
    Lieberman DA; Weiss DG; Harford WV; Ahnen DJ; Provenzale D; Sontag SJ; Schnell TG; Chejfec G; Campbell DR; Kidao J; Bond JH; Nelson DB; Triadafilopoulos G; Ramirez FC; Collins JF; Johnston TK; McQuaid KR; Garewal H; Sampliner RE; Esquivel R; Robertson D
    Gastroenterology; 2007 Oct; 133(4):1077-85. PubMed ID: 17698067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study.
    van Heijningen EM; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Lesterhuis W; Ter Borg F; Vecht J; De Jonge V; Spoelstra P; Engels L; Bolwerk CJ; Timmer R; Kleibeuker JH; Koornstra JJ; van Ballegooijen M; Steyerberg EW
    Gastroenterology; 2013 Jun; 144(7):1410-8. PubMed ID: 23499951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
    Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
    Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for advanced colorectal adenomas: a pooled analysis.
    Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence.
    Nusko G; Hahn EG; Mansmann U
    Scand J Gastroenterol; 2009; 44(6):736-44. PubMed ID: 19277927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
    Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
    Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.